Live Breaking News & Updates on Anaptysbio Daily|Page 5

Stay updated with breaking news from Anaptysbio daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Hold" by Brokerages

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Hold" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Dennis Mulroy , Paulf Lizzul , Anaptysbio Inc , Securities Exchange Commission , Charles Schwab Investment Management Inc , Ensign Peak Advisors Inc , Get Free Report , Exchange Commission , Peak Advisors Inc , Schwab Investment Management , State Teachers Retirement System , Get Free , Anaptysbio Daily ,

AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 5,110,000 shares, an increase of 13.1% from the January 15th total of 4,520,000 shares. Currently, 22.2% of the company’s stock are sold short. Based […] ....

Daniel Faga , Zurcher Kantonalbank Zurich Cantonalbank , Dennis Mulroy , Tower Research Capital , China Universal Asset Management Co , Anaptysbio Inc , Get Free Report , Research Capital , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Anaptysbio Daily , Nasdaq Anab ,

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells 2,554 Shares of Stock

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Paul F. Lizzul sold 2,554 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $21.81, for a total transaction of $55,702.74. Following the completion of the sale, the insider now owns 10,118 shares of the […] ....

Paulf Lizzul , Zurcher Kantonalbank Zurich Cantonalbank , Deutsche Bank , Securities Exchange Commission , Anaptysbio Company Profile , Anaptysbio Inc , Tower Research Capital , Get Free Report , Exchange Commission , Bio Stock Down , Research Capital , Kantonalbank Zurich Cantonalbank , Anaptysbio Daily , Nasdaq Anab , Insider Trading , Nsider Trades ,

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells $55,702.74 in Stock

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Paul F. Lizzul sold 2,554 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $21.81, for a total value of $55,702.74. Following the completion of the sale, the insider now directly owns 10,118 shares of […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Paulf Lizzul , Fred Alger Management , Anaptysbio Inc , Tower Research Capital , Get Free Report , Research Capital , Kantonalbank Zurich Cantonalbank , Anaptysbio Daily , Nasdaq Anab , Insider Trading , Nsider Trades ,

Dennis Mulroy Sells 2,180 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) CFO Dennis Mulroy sold 2,180 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $21.81, for a total transaction of $47,545.80. Following the transaction, the chief financial officer now directly owns 4,029 shares of the company’s […] ....

Dennis Mulroy , Dimensional Fund Advisors , Metlife Investment Management , Anaptysbio Inc , Swiss National Bank , Charles Schwab Investment Management Inc , Get Free Report , National Bank , Life Investment Management , Fund Advisors , Charles Schwab Investment Management , Schwab Investment Management , Anaptysbio Daily , Nasdaq Anab , Insider Trading , Nsider Trades ,